Head and neck squamous cell carcinoma: optimizing the therapeutic index. (Q36185629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Head and neck squamous cell carcinoma: optimizing the therapeutic index (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

head and neck squamous cell carcinoma

30 December 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Angel I Blanco

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

501-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Altered fractionation trials in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Radiotherapy for cancer of the head and neck: altered fractionation regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Time-dose factors in radiotherapy: a review of the human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Inverse planning algorithms for external beam radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Barriers to winning the battle with head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

The role of concurrent chemotherapy and radiation in the management of patients with squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Biological staging of head and neck cancer and its role in developing effective treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Epidermal growth factor receptor as a therapeutic target in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Clinical implications of biomarkers in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Emerging molecular markers of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.501

21 January 2018

Identifiers

DOI

10.1586/14737140.5.3.501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16001957%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference